Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients
Reneau, John C., Asante, Dennis, Van Houten, Holly, Sangaralingham, Lindsey R., Buadi, Francis K., Lerman, Amir, Herrmann, JoergLanguage:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.24599
Date:
November, 2016
File:
PDF, 714 KB
english, 2016